Varicella vaccine: the Japanese experience
1Department of Pediatrics, Fujita Health University School of Medicine, Aichi, Japan.
Abstract:
Varicella vaccine developed by the Biken Institute (Osaka, Japan) was administered to 1.39 million subjects in Japan and 1.93 million in Korea between 1987 and 1993. Six years after licensure, it was assessed for safety and efficacy under the regulatory requirements of the Japanese government. Clinical symptoms were reported in 6.9% (580/8429) of vaccines (mostly healthy children) and seroconversion in 91.5% (2347/2565), and the mean antibody titer 1 month after immunization was 12.2. Despite 100 well-documented contacts with varicella patients, only 2 (2%) developed breakthrough varicella with very mild clinical features within 12 months of vaccination. Immunologic tests in 26 recipients showed presence of humoral and cellular immunities to varicella-zoster virus (VZV) for > or = 20 years. These data indicate that this live attenuated varicella vaccine provides long-term protective immunity against VZV infection.
More Related Videos
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
06:22Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
Published on: February 10, 2023
Related Concept Videos
Vaccinations
Vaccines
Diphtheria
Smallpox
Chickenpox
Poliomyelitis
